BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10483841)

  • 1. Psychotherapy with borderline patients: II. A preliminary cost benefit study.
    Stevenson J; Meares R
    Aust N Z J Psychiatry; 1999 Aug; 33(4):473-7; discussion 478-81. PubMed ID: 10483841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness and Budget Impact of Specialized Psychotherapy for Borderline Personality Disorder: A Synthesis of the Evidence.
    Wetzelaer P; Lokkerbo J; Arntz A; van Aselt T; Smit F; Evers S
    J Ment Health Policy Econ; 2017 Dec; 20(4):177-190. PubMed ID: 29300704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Out-patient psychotherapy for borderline personality disorder: cost-effectiveness of schema-focused therapy v. transference-focused psychotherapy.
    van Asselt AD; Dirksen CD; Arntz A; Giesen-Bloo JH; van Dyck R; Spinhoven P; van Tilburg W; Kremers IP; Nadort M; Severens JL
    Br J Psychiatry; 2008 Jun; 192(6):450-7. PubMed ID: 18515897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncertain efficacy for psychotherapy for borderline patients: a methodologist's lament.
    Reznik R
    Aust N Z J Psychiatry; 2000 Aug; 34(4):695-7. PubMed ID: 10954405
    [No Abstract]   [Full Text] [Related]  

  • 5. Societal cost-of-illness in patients with borderline personality disorder one year before, during and after dialectical behavior therapy in routine outpatient care.
    Wagner T; Fydrich T; Stiglmayr C; Marschall P; Salize HJ; Renneberg B; Fleßa S; Roepke S
    Behav Res Ther; 2014 Oct; 61():12-22. PubMed ID: 25113523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of psychotherapy for cluster C personality disorders: a decision-analytic model in the Netherlands.
    Soeteman DI; Verheul R; Meerman AM; Ziegler U; Rossum BV; Delimon J; Rijnierse P; Thunnissen M; Busschbach JJ; Kim JJ
    J Clin Psychiatry; 2011 Jan; 72(1):51-9. PubMed ID: 21034679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based cost-offset estimation for the treatment of borderline personality disorder: projected costs in a currently running, ideal health system.
    Wunsch EM; Kliem S; Kröger C
    Behav Res Ther; 2014 Sep; 60():1-7. PubMed ID: 25014129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An outcome study of psychotherapy for patients with borderline personality disorder.
    Stevenson J; Meares R
    Am J Psychiatry; 1992 Mar; 149(3):358-62. PubMed ID: 1536275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic impact of psychotherapy: a review.
    Gabbard GO; Lazar SG; Hornberger J; Spiegel D
    Am J Psychiatry; 1997 Feb; 154(2):147-55. PubMed ID: 9016261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost of borderline personality disorder: societal cost of illness in BPD-patients.
    van Asselt AD; Dirksen CD; Arntz A; Severens JL
    Eur Psychiatry; 2007 Sep; 22(6):354-61. PubMed ID: 17544636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care.
    Bateman A; Fonagy P
    Am J Psychiatry; 2003 Jan; 160(1):169-71. PubMed ID: 12505818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of psychological treatment for borderline personality disorder: Systematic review and cost offset analysis of economic evaluations.
    Meuldijk D; McCarthy A; Bourke ME; Grenyer BF
    PLoS One; 2017; 12(3):e0171592. PubMed ID: 28249032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy.
    Giesen-Bloo J; van Dyck R; Spinhoven P; van Tilburg W; Dirksen C; van Asselt T; Kremers I; Nadort M; Arntz A
    Arch Gen Psychiatry; 2006 Jun; 63(6):649-58. PubMed ID: 16754838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical evidence and psychotherapy: a growing scientific base.
    Gabbard GO
    Am J Psychiatry; 2001 Jan; 158(1):1-3. PubMed ID: 11136624
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychotherapy with borderline patients: I. A comparison between treated and untreated cohorts.
    Meares R; Stevenson J; Comerford A
    Aust N Z J Psychiatry; 1999 Aug; 33(4):467-72; discussion 478-81. PubMed ID: 10483840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to deal with cost differences at baseline.
    van Asselt AD; van Mastrigt GA; Dirksen CD; Arntz A; Severens JL; Kessels AG
    Pharmacoeconomics; 2009; 27(6):519-28. PubMed ID: 19640014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in Identity Diffusion and Psychopathology in a Specialized Inpatient Treatment for Borderline Personality Disorder.
    Sollberger D; Gremaud-Heitz D; Riemenschneider A; Agarwalla P; Benecke C; Schwald O; Küchenhoff J; Walter M; Dammann G
    Clin Psychol Psychother; 2015; 22(6):559-69. PubMed ID: 25147094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Economic Analysis of Psychotherapy for Borderline Personality Disorder Patients.
    Hall J; Caleo S; Stevenson J; Meares R
    J Ment Health Policy Econ; 2001 Mar; 4(1):3-8. PubMed ID: 11967460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary study of the naturalistic course of non-manualized psychotherapy for outpatients with borderline personality disorder: Patient characteristics, attrition and outcome.
    Nysaeter TE; Nordahl HM; Havik OE
    Nord J Psychiatry; 2010 Apr; 64(2):87-93. PubMed ID: 19958254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising psychotherapies for personality disorders.
    Hadjipavlou G; Ogrodniczuk JS
    Can J Psychiatry; 2010 Apr; 55(4):202-10. PubMed ID: 20416143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.